ArticleBreast (Edinburgh, Scotland)2020

A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK).

Min Ho Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.